# Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-iii-study-of-cisplatin-plus-irinotecan-versus-carboplatin-plus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuichiro Ohe,Yasuo Ohashi,Kaoru Kubota,Tomohide Tamura,Kazuhiko Nakagawa,Shunichi Negoro,Yutaka Nishiwaki,Nagahiro Saijo,Y Ariyoshi,M. Fukuoka |
| Citations | 637 |
| DOI | 10.1093/annonc/mdl377 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2151090489 |
| PMID | 17079694 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Yasuo Ohashi](https://scholariq.org/researchers/yasuo-ohashi/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.